Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when AGL files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsagilon health reports Q1 2026 earnings results
Filed May 6, 2026 · Period ending May 6, 2026 · ~1 min read
Key Changes
-
high
Company issued press release disclosing financial results for the three months ended March 31, 2026. Actual figures are contained in the attached press release exhibit, not in the 8-K body itself.
Item 2.02 verify on EDGAR → -
medium
This is a standard quarterly earnings disclosure filing. Investors should review Exhibit 99.1 (the press release) for specific revenue, earnings, and guidance details.
8-K: Earnings view on EDGAR →
Summary
agilon health filed an 8-K on May 6, 2026 to announce its first quarter 2026 financial results. The filing itself is procedural—it references a press release (Exhibit 99.1) that contains the actual earnings figures, but does not include those numbers in the 8-K body. This is standard practice for quarterly earnings announcements.
Retail investors should review the attached press release for key metrics including revenue, adjusted EBITDA, patient enrollment trends, and any updated full-year guidance. As a value-based care platform company, agilon's quarterly performance typically hinges on physician partnership growth and medical cost management. Watch for management commentary on medical cost trends and any changes to 2026 guidance in the earnings call or press release, as these will signal whether the company is on track with its growth and profitability targets.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
agilon health disclosed Q1 2026 financial results via press release on May 6, 2026.
Added in current filing · verify on EDGAR →
On May 6, 2026, agilon health, inc. (the “Company”), a Delaware corporation, issued a press release setting forth its financial results for the three months ended March 31, 2026.
The company announced its first quarter 2026 financial results through a press release. The 8-K itself does not contain the actual financial figures, which are provided in the attached press release exhibit. This is a standard earnings disclosure filing.
Event · Item 9.01 — Financial Statements and Exhibits
agilon health filed an 8-K attaching a press release dated May 6, 2026; no material event details disclosed in the 8-K body itself.
Added in current filing · verify on EDGAR →
Press Release dated May 6, 2026.
The 8-K references an attached press release dated May 6, 2026 (Exhibit 99.1). The 8-K body does not disclose the content or subject matter of the press release, so the nature and materiality of the event cannot be determined from this filing alone. Investors should review Exhibit 99.1 directly to understand what was announced.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify